NEU 5.31% $14.80 neuren pharmaceuticals limited

SP is vulnerable from here. One minor setback on ongoing trial...

  1. 456 Posts.
    lightbulb Created with Sketch. 469
    SP is vulnerable from here. One minor setback on ongoing trial plans and we may see it hammered further. Near term weak support around $1.03-$1.07 but in current environment and with lack of appetite for this company it may give away soon. Next, support comes around 96-98c historically it was strong but that was in much better market while all indexes were strongly bullish, not sure how much it holds at @97c level in current scenario.

    The meaningful support is around 80-85c which we may call a bottom bottom, so would not surprise if SP falls below 97c in coming weeks.
    https://hotcopper.com.au/data/attachments/2517/2517164-126dd6fda2a7e3c549797b6eadbd92cb.jpg
    Interested in knowing contrary views as I want to make up my mind on whether to keep holding a lot or completely get out of this.

    DYOR. GLTAH
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.80
Change
-0.830(5.31%)
Mkt cap ! $1.891B
Open High Low Value Volume
$15.65 $15.72 $14.76 $11.61M 772.4K

Buyers (Bids)

No. Vol. Price($)
1 1392 $14.80
 

Sellers (Offers)

Price($) Vol. No.
$14.90 1553 2
View Market Depth
Last trade - 16.10pm 19/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.